Navigation Links
Reportlinker Adds H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays) Report
Date:9/24/2009

NEW YORK, Sept. 24 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)

http://www.reportlinker.com/p0119228/H1N1-(Swine-Influenza)-Market-Assessment-(Latest-Data-Company-Profiles-Implications-for-Immunoassays-and-Molecular-Assays).html

The outbreak of swine flu is highlighting the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen.

Regardless of the eventual severity of the epidemic, there will be distinct market impact on both immunoassay and molecular test makers, according to the report. The makers of certain tests will benefit both in terms of sales and more broadly in recognition that their products play a vital role in making the public health community significantly better prepared for this possible pandemic than 1968 or before.

The report examines:

  • Market Impact likely for immunoassays and molecular testing.
  • Lessons from previous epidemics, likely impact on both immunoassays and molecular testing.
  • Overview of the H1N1 strain as compared to other.
  • Immunoassay and Molecular Test Products Available on the Market
  • Developments in the last few days of significance to the diagnostic industry.
  • Profiles of nearly 25 specific manufacturers active in this space.

The report focuses almost exclusively on the in vitro diagnostic industry as it applies to work being done by commercial entities and products that are either in development or have been brought to market.

The market assessment provided has been assembled based on publicly available information. Company sales data and other quantitative evaluations of the markets for flu diagnostics have been developed based on publicly available information and are expressed in US dollars, no adjustments have been made for currency exchange fluctuations.

Under normal circumstances, a report of this genre would be assembled from information derived from primary and secondary sources. However, in the short time it took to research and write this report, almost all of the major scientific and industry experts were occupied with the extraordinary task of preparing for a pandemic.

Therefore the information contained in this report has been assembled from a vast array of scientific and market publications, government sources, analyzed by a professional analyst.

CHAPTER ONE: EXECUTIVE SUMMARY

  • Background
  • Exhibit 1: Flu Epidemics Compared to Present 1918-Today
  • Scope And Methodology
  • Point of View
  • Information Sources

CHAPTER TWO: 2009 SWINE INFLUENZA AND OTHER FLU EPIDEMICS

  • Influenza Overview
  • Overview of Virus Types
  • What's So Special About This Latest Flu?
  • Flu Therapeutics
  • WHO Global Influenza Preparedness Plan

CHAPTER THREE: FLU DIAGNOSTICS

  • Background
  • Exhibit 2: Influenza Test Innovations, 2009 (Company, Technology, Test Details, Status)
  • Immunoassays
    • Rapid Testing
    • Market Performance of Rapid Test
    • New Entrant Possibility
    • Conclusion: Impact of Swine Flu on Rapid Testing
  • Molecular Assays
    • Molecular Influenza Detection Techniques
    • PCR, Sequencing or Both
    • Lessons and Market Impact of the H5N1 Epidemic

CHAPTER FOUR: PROGNOSIS FOR A/H1N1

  • Background
  • Pandemic - Where? When?
    • 1976 Hsw1N1 Swine Flu Case
    • Comparing Past Flu Epidemics to 2009
    • International Reaction
  • Swine Flu and the IVD Industry
    • Origin of Flu Virus Mixes
    • PCR Test Development
    • Late-Breaking Research Developments
    • Use of Rapid Tests in Current Epidemic

CHAPTER FIVE: COMPANIES AND PRODUCTS IMPACTED BY SWINE FLU EPIDEMIC

  • Immunoassays
    • 3M Medical Diagnostics
    • Becton, Dickinson and Company (BD)
    • Genzyme Corporation
    • Inverness Medical Innovations
    • Meridian Bioscience, Inc.
    • Quidel Corporation
    • Remel, Inc.
    • Response Biomedical Corporation
  • Molecular Tests
    • Arbor Vita Corporation
    • CombiMatrix Molecular Diagnostics (CMDX)
    • Diagnostic HYBRIDS, Inc. (DHI)
    • eGene Inc.
    • Eiken Chemical Co., Ltd
    • Life Technologies/Applied Biosystems/ Invitrogen Corporation (ABI)
    • Lab21
    • Laboratory Corporation of America Holdings (LabCorp)
    • Luminex Corporation
    • Nanogen
    • Prodesse Inc.
    • Qiagen N.V.
    • Seegene Inc.
    • Veredus Laboratories Pte

To order this report:

H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)

http://www.reportlinker.com/p0119228/H1N1-(Swine-Influenza)-Market-Assessment-(Latest-Data-Company-Profiles-Implications-for-Immunoassays-and-Molecular-Assays).html

More market research reports here!

    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)652-2626
    Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Reportlinker Adds Biologic Imaging Reagents: Technologies and Global Markets Report
2. Reportlinker Adds Dermatological Therapeutics: Global Markets Report
3. Reportlinker Adds Markets for Advanced Wound Care Technologies Report
4. Reportlinker Adds Antiseptics and Disinfectants Report
5. Reportlinker Adds Commercial Amino Acids Report
6. Reportlinker Adds Membrane & Separation Technology News Review, 2008 Report
7. Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report
8. Reportlinker Adds Pediatric Health Care Products and Services Report
9. Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report
10. Reportlinker Adds 2008/2009 Healthcare Research Review Report
11. Reportlinker Adds Therapeutics and Diagnostics for Womens Disorders Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... (PRWEB) , ... January 19, ... ... introducing the Aerolib Learning Management System: an On-demand E-learning system for Clinical ... and Hospital Administration that is based on Aerolib`s successful education methodology of ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... SF expansion and facility enhancement of their 503A compounding pharmacy located in Ocala, ... growing demand of physicians and patients throughout the United States for high-quality human ...
(Date:1/19/2017)... ... 2017 , ... This month, the CEO and Clinical Director of Sober Living ... center in Delray Beach, Florida has been changed from Sober Living Outpatient to ‘SLO ... Seymour Hoffman and Chris Farley are dying from heroin overdoses, but thousands of unnamed ...
(Date:1/19/2017)... ... 19, 2017 , ... WhoHaha , a digital media company dedicated to ... (AHA) to produce a three-part video series that uses humor to highlight ways to ... launch of AHA’s Healthy For Good™ movement, which is designed to inspire all Americans ...
(Date:1/19/2017)... ... 2017 , ... Cosmetic Town, an online plastic surgery community, begins 2017 with ... easier for their readers to get the information they desire. The procedures are now ... techniques used on those particular areas. , “We are excited to streamline our listings ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , , Marks E-QURE , ... agreement, following similar agreements in Israel and ... 5 billion global market ... leader in medical devices for the treatment of advanced wound care, announced today ... in Colombia for the Company,s patented Bio-electrical Signal Therapy ...
(Date:1/19/2017)... Jan. 18, 2017 The Global Therapy Partnering ... access to partnering deals and agreements entered into by ... partnering deals - Top deals by value - Deals ... technology type The report provides understanding and access ... the world,s leading healthcare companies. The report provides ...
(Date:1/19/2017)... , Jan. 18, 2017   Synthetic Biologics, ... company developing therapeutics designed to preserve the microbiome ... today confirmed plans to initiate a Phase 2b/3 ... reformulation of lovastatin lactone designed to reduce methane ... in the gut to treat the underlying cause ...
Breaking Medicine Technology: